celecoxib has been researched along with thiazolyl blue in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, AT; Chan, CM; Ma, BB; Wong, SC | 1 |
| Cho, SJ; Jung, HC; Kim, JS; Kim, N; Song, IS | 1 |
| Guo, CY; Hu, HL; Liu, J; Wang, XP; Xie, CG; Xu, XF; Yu, YC | 1 |
| Li, C; Li, H; Lin, J; Liu, A; Liu, Y | 1 |
| Babu, PP; Geeviman, K; Ramulu, C; Sareddy, GR | 1 |
| Gan, L; Hu, GQ; Hu, GY; Jiang, JZ; Li, WW; Liu, DB; Long, GX; Mei, Q; Sun, W; Wang, JF | 1 |
| Gan, L; Hu, GQ; Hu, GY; Jiang, JZ; Li, WW; Liu, DB; Liu, SF; Long, GX; Mei, Q; Sun, W; Wang, JF | 1 |
7 other study(ies) available for celecoxib and thiazolyl blue
| Article | Year |
|---|---|
Celecoxib induces dose dependent growth inhibition in nasopharyngeal carcinoma cell lines independent of cyclooxygenase-2 expression.
Topics: Blotting, Western; Celecoxib; Cell Division; Cell Line, Tumor; Cyclin D1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Humans; Nasopharyngeal Neoplasms; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Tetrazolium Salts; Thiazoles | 2005 |
The anti-cancer effect of COX-2 inhibitors on gastric cancer cells.
Topics: Adenocarcinoma; Apoptosis; Celecoxib; Cell Cycle; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Dinoprostone; Humans; Microscopy, Fluorescence; Pyrazoles; Stomach Neoplasms; Sulfonamides; Tetrazolium Salts; Thiazoles | 2007 |
Selective inhibition of cyclooxygenase-2 suppresses the growth of pancreatic cancer cells in vitro and in vivo.
Topics: Administration, Oral; Aged; Animals; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Female; Humans; Immunohistochemistry; In Vitro Techniques; Male; Mice; Mice, Nude; Middle Aged; Nitrobenzenes; Pancreatic Neoplasms; Proliferating Cell Nuclear Antigen; Pyrazoles; Radioligand Assay; Sulfonamides; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2008 |
Celecoxib inhibits interleukin-6/interleukin-6 receptor-induced JAK2/STAT3 phosphorylation in human hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; DNA; Humans; Immunohistochemistry; Interleukin-6; Janus Kinase 2; Liver Neoplasms; Microscopy, Fluorescence; Phosphorylation; Pyrazoles; Receptors, Interleukin-6; STAT3 Transcription Factor; Sulfonamides; Tetrazolium Salts; Thiazoles | 2011 |
The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-κB pathway.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Blotting, Western; Brain Neoplasms; Celecoxib; Cell Line, Tumor; Cell Nucleus; Cell Survival; Colony-Forming Units Assay; Coloring Agents; Cyclooxygenase 2 Inhibitors; Cytosol; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Fluorescent Antibody Technique; Glioblastoma; Humans; I-kappa B Proteins; In Situ Nick-End Labeling; NF-kappa B; Protein Transport; Pyrazoles; Signal Transduction; Sulfonamides; Tetrazolium Salts; Thiazoles; Tumor Necrosis Factor-alpha | 2012 |
Cyclooxygenase-2 inhibitor celecoxib suppresses invasion and migration of nasopharyngeal carcinoma cell lines through a decrease in matrix metalloproteinase-2 and -9 activity.
Topics: Carcinoma; Celecoxib; Cell Line, Tumor; Cell Movement; Cell Proliferation; Coloring Agents; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Humans; Indicators and Reagents; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Pyrazoles; Sulfonamides; Tetrazolium Salts; Thiazoles; Wound Healing | 2014 |
Anticancer effects of celecoxib through inhibiton of STAT3 phosphorylation and AKT phosphorylation in nasopharyngeal carcinoma cell lines.
Topics: Antineoplastic Agents; Blotting, Western; Celecoxib; Cell Line, Tumor; Cell Proliferation; Coloring Agents; Cyclooxygenase 2 Inhibitors; Humans; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrazoles; STAT3 Transcription Factor; Sulfonamides; Tetrazolium Salts; Thiazoles | 2014 |